Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
about
Recent Advances in Understanding and Managing Tourette SyndromeDiagnosis and treatment of dystoniaTourette Syndrome: UpdateTemporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper.Tetrabenazine: Spotlight on Drug Review.How Much Do We Know about Adult-onset Primary Tics? Prevalence, Epidemiology, and Clinical FeaturesTics in the Pediatric Population: Pragmatic ManagementMeige's syndromeDrug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.Liquid chromatography-tandem mass spectrometric assay for the determination of tetrabenazine and its active metabolites in human plasma: a pharmacokinetic study.Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.Challenging neurological symptoms in paediatric palliative care: An approach to symptom evaluation and management in children with neurological impairment.A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2Treatment of neurolept-induced tardive dyskinesiaEffort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression.Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.The neuropsychiatry of inborn errors of metabolism.The vesicular monoamine transporter 2: an underexplored pharmacological target.The role of dopamine in Huntington's disease.Tourette syndrome deep brain stimulation: a review and updated recommendations.Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.Dopamine and Huntington's disease.Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management.Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.Childhood dystonias.Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine ModulationClinical Management of Dystonia in Childhood.Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study.Not All Antidepressants Are Created Equal: Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior.Impaired motor speech performance in Huntington's disease.Tourette syndrome: a disorder of the social decision-making network.Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome.Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat.Valbenazine for the treatment of tardive dyskinesia.Treatment of tardive dyskinesia with tetrabenazine or valbenazine: a systematic review.Treatment options for chorea.Pharmacogenetic study of antipsychotic induced acute extrapyramidal symptoms in a first episode psychosis cohort: role of dopamine, serotonin and glutamate candidate genes.Valbenazine granted breakthrough drug status for treating tardive dyskinesia.
P2860
Q26766090-EA4F8205-06EE-439A-BB61-73ECE4D7A91FQ26830473-D6C3D096-156D-4AD0-B6B3-214D5D7A0B73Q27022064-6C4FF431-29FC-46BF-B507-0DEEF70A5E3FQ27686833-8D6EC405-E3A0-4D28-8292-B454EA59E6C1Q27692599-54D2AC60-22A6-44D5-88F8-44CA083B692CQ30234351-C8986FCB-9672-4A7D-9B45-6E763FC89C97Q33577672-5005C42D-3626-404B-A951-C8AD2DFF2A8BQ33820592-636B4A1A-DAD4-49EB-BF25-2A80585D42E4Q34522634-FA665C1E-204D-44F7-8814-B4FDB7ED8A9BQ34547558-B84CBF93-AE41-43DB-AA71-03CA505CF526Q34556884-F1CB3E12-0AA0-4B97-995C-929532EF055FQ34760266-6F9EFB1D-6CAE-4CA5-A59F-B8509B94ACDAQ35486622-E4B38BF4-FBCB-4F1F-9F1D-911E777C4369Q36128614-D30B4460-4E12-4EB4-AB3F-DF841038ACA6Q37198420-853542AE-9EDB-43FD-AC3F-990AE5545658Q37362447-D1595E18-692C-4C21-AA7E-5C0BFF06BDB7Q37612442-348FB789-1B91-4D69-A254-8416C54AD079Q37707292-0EDADF01-4F93-4F61-B2C6-8FA016D28EB9Q38108763-801416AA-1D99-4263-9216-C9C9A72E6058Q38176494-0B3E5F0E-A738-4BBF-9E75-187AA4C4C621Q38223504-9394EBBA-838A-45E6-90B3-AAC4FB5F9A65Q38283441-7DB2A5E1-4320-4544-A8A1-F16EFDAB654CQ38306593-492513FE-E51A-4F29-BDE4-133178DBD45DQ38379277-E8D4422C-3FEE-4A4D-80A2-9C3F0E8AC44BQ38657158-08C42BF5-0D3D-45FB-85D8-450B1F656DBAQ38836831-658C9B67-F511-4C69-AA75-8F2A0604ADABQ39036581-31DF17FA-9D5C-4FD8-B10D-8DFB7EA24A79Q39041217-49FB5EE9-A7F9-4E10-A278-57CC05E44D20Q39377592-B083E6C3-610A-46E9-8EBD-51E7B532EE9CQ42372442-572B0FC0-9877-4453-894E-4DA0BBFB6A94Q43096386-D062FB0D-C926-45FA-BBB2-09197510F8E5Q45295810-E31991D1-278E-406D-9D61-03CC85F53825Q46279291-722C0B40-5EA6-4832-A3EF-50D762ED9D9FQ47559197-9CCC7EF1-D8CD-4BD3-9B7F-BE2F9DE5F436Q47586487-0397B8F5-4385-4A39-B1CF-0E5361C7AE01Q47670227-CA299425-DEEC-499E-BE8F-28EB41266FD5Q47753620-F4B1A87C-A349-473C-9E39-72F7F082B280Q47977953-E00E9500-F080-45C7-A218-DB96F3E31E29Q48006592-64128B3C-D7AB-47B0-B453-01B60E34FBB0Q48088881-10624D89-26CE-4B0E-A46B-CCA0AD8FD94D
P2860
Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Tetrabenazine for the treatmen ...... s: a review of the literature.
@ast
Tetrabenazine for the treatmen ...... s: a review of the literature.
@en
Tetrabenazine for the treatmen ...... s: a review of the literature.
@nl
type
label
Tetrabenazine for the treatmen ...... s: a review of the literature.
@ast
Tetrabenazine for the treatmen ...... s: a review of the literature.
@en
Tetrabenazine for the treatmen ...... s: a review of the literature.
@nl
prefLabel
Tetrabenazine for the treatmen ...... s: a review of the literature.
@ast
Tetrabenazine for the treatmen ...... s: a review of the literature.
@en
Tetrabenazine for the treatmen ...... s: a review of the literature.
@nl
P1476
Tetrabenazine for the treatmen ...... rs: a review of the literature
@en
P2093
Jack J Chen
William G Ondo
P304
P356
10.1016/J.CLINTHERA.2012.06.010
P577
2012-06-28T00:00:00Z